"Wegovy," an FDA-approved weight loss injection medication since June 2021, contains semaglutide as its key ingredient, initially designed for treating type 2 diabetes.
Administered via weekly injections, Wegovy is tailored to aid those grappling with obesity or excess weight in their weight loss journey.
Its mechanism involves appetite reduction and increased feelings of fullness, leading to reduced calorie intake and subsequent weight loss.
Importantly, Wegovy is not a standalone weight loss solution and should be complemented by a balanced diet and exercise regimen. As with any medication, potential side effects exist, necessitating consultation with healthcare professionals to determine its suitability for individual circumstances.
wegovy functions by suppressing appetite and controlling food intake through the active ingredient semaglutide, which imitates the hormone responsible for regulating appetite. As a result, you experience a longer-lasting feeling of fullness and reduced hunger, leading to lower calorie intake and potential weight loss.
For optimal results, wegovy should be used in conjunction with lifestyle modifications such as a healthier diet and increased exercise. In fact, studies have shown that around 84% of users lost at least 5% of their weight when using wegovy along with lifestyle changes, compared to only 40% who lost 5% without lifestyle modifications.
For optimal results, wegovy should be used in conjunction with lifestyle modifications such as a healthier diet and increased exercise. In fact, studies have shown that around 84% of users lost at least 5% of their weight when using wegovy along with lifestyle changes, compared to only 40% who lost 5% without lifestyle modifications.
In comparison, only 60% of individuals using Saxenda® along with a reduced calorie diet and physical activity counselling lost 5% of their weight.
wegovy injections are administered once a week into the tummy, thigh, or upper arm, with varying dosages available depending on where you are in your treatment journey.
To ensure you can manage any potential side effects, the dosage is gradually increased through a process known as titration until a sustained dose is reached. If the treatment is well-tolerated, the dosing schedule will typically follow these guidelines:
Side effects are possible with any medication, but they tend to be mild and not experienced by everyone. In one clinical trial, only 5.3% of patients discontinued Wegovy due to side effects.
The most frequent side effects include headaches, vomiting, diarrhoea, constipation, nausea, abdominal pain, and fatigue. These typically improve as your body adapts to the medication. To minimize the risk of side effects, consider gradually increasing the dose every 4 weeks.
If side effects persist or worsen, consult your doctor or pharmacist for guidance.
See section 4 of the patient information leaflet for a complete list of possible side effects.
